Clinical Trial Update: Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018 [NA]

View source ↗

Summary

Baxter completed a clinical trial of the Timmy3 Module assessing clinical accuracy under ISO 80601-2-56:2017 + A1 2018 for febrile illness; results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Illness

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Febrile Illness | NA | Status: COMPLETED | Results posted: 2026-03-11